Conversion or Reversion of Interferon γ Release Assays for Mycobacterium tuberculosis Infection: A Systematic Review and Meta-analysis
Clinical Infectious Diseases · 05.02.2025 · 80 (1) · 168-179
DOI: 10.1093/cid/ciae357 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Infectious Diseases, online erschienen am 02.07.2024. Verfasst von Mao-Shui Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lab Medicine, Shandong Public Health Clinical Center, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Interferon-gamma Release Tests, Latent Tuberculosis, Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Shandong government, Taishan Scholar Project, Australian Respiratory Council.
Abstract (Originalsprache)
Background
Interferon γ release assays (IGRAs) are widely used for diagnosis of latent tuberculosis infection. However, with repeated testing, IGRA transformation (conversion or reversion) may be detected and is challenging to interpret. We reviewed the frequency of and risk factors for IGRA transformation.
Methods
We screened public databases for studies of human participants that reported the frequency of IGRA transformation. We extracted study and participant characteristics, details of IGRA testing and results. We calculated the pooled frequency of IGRA transformation (and transient transformation) and examined associated risk factors.
Results
The pooled frequency of IGRA conversion or reversion from 244 studies was estimated at 7.3% (95% confidence interval [CI], 6.1%–8.5%) or 22.8% (20.1%–25.7%), respectively. Transient conversion or reversion were estimated at 46.0% (95% CI, 35.7%–56.4%) or 19.6% (9.2%–31.7%) of conversion or reversion events respectively. Indeterminate results seldom reverted to positive (1.2% [95% CI, .1%–3.5%]). IGRA results in the borderline-positive or borderline-negative range were associated with increased risk of conversion or reversion (pooled odds ratio [OR] for conversion, 4.15 [95% CI, 3.00–5.30]; pooled OR for reversion, 4.06 [3.07–5.06]). BCG vaccination was associated with decreased risk of conversion (OR, 0.70 [95% CI, .56–.84]), cigarette smoking with decreased risk of reversion (0.44 [.06–.82]), and female sex with decreased risk of either conversion or reversion (OR for conversion, 0.66 [.58–.75]; OR for reversion, 0.46 [.31–.61]).
Conclusions
IGRA conversion is less common than reversion, and frequently transient. Research is needed to determine whether individuals with reversion would benefit from tuberculosis-preventive treatment. Retesting of people with indeterminate results is probably not indicated, because indeterminate results seldom revert to positive.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Lab Medicine, Shandong Public Health Clinical Center, Shandong University, Jinan, China.
- Shandong Key Laboratory of Infectious Respiratory Disease, Jinan, China.
- School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
- Faculty of Health Sciences, School of Population Health, Curtin University, Perth, WA, Australia.
- Geospatial and Tuberculosis Research Team, Telethon Kids Institute, Perth, WA, Australia.
- Department of Cardiovascular Surgery, Shandong Public Health Clinical Center, Shandong University, Jinan, China.
ORCID-Profile: Mao-Shui Wang
Förderung
- Shandong government
- Taishan Scholar Project
- Australian Respiratory Council
- National Health & Medical Research Council
- Department of Health of Western Australia
Zitieren
APA
Wang, M. S., Li-Hunnam, J., Chen, Y. L., Gilmour, B., Alene, K. A., Zhang, Y. A., & Nicol, M. P. (2025). Conversion or Reversion of Interferon γ Release Assays for Mycobacterium tuberculosis Infection: A Systematic Review and Meta-analysis. Clinical Infectious Diseases, 80(1), 168-179. https://doi.org/10.1093/cid/ciae357
Vancouver
Wang MS, Li-Hunnam J, Chen YL, Gilmour B, Alene KA, Zhang YA, et al. Conversion or Reversion of Interferon γ Release Assays for Mycobacterium tuberculosis Infection: A Systematic Review and Meta-analysis. Clinical Infectious Diseases. 2025;80(1):168-179. doi:10.1093/cid/ciae357
BibTeX
@article{Wang2025,
author = {Wang, Mao-Shui and Li-Hunnam, Jarrod and Chen, Ya-Li and Gilmour, Beth and Alene, Kefyalew Addis and Zhang, Yan-An and Nicol, Mark P},
title = {Conversion or Reversion of Interferon γ Release Assays for Mycobacterium tuberculosis Infection: A Systematic Review and Meta-analysis},
journal = {Clinical Infectious Diseases},
year = {2025},
volume = {80},
number = {1},
pages = {168--179},
doi = {10.1093/cid/ciae357}
}
EUVIMED